A detailed history of Connectus Wealth, LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Connectus Wealth, LLC holds 40,472 shares of BMY stock, worth $2.15 Million. This represents 0.05% of its overall portfolio holdings.

Number of Shares
40,472
Previous 25,779 57.0%
Holding current value
$2.15 Million
Previous $1.32 Million 65.96%
% of portfolio
0.05%
Previous 0.02%

Shares

10 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 14, 2024

BUY
$47.98 - $54.4 $704,970 - $799,299
14,693 Added 57.0%
40,472 $2.19 Million
Q4 2023

Feb 14, 2024

BUY
$48.48 - $57.85 $232,267 - $277,159
4,791 Added 22.83%
25,779 $1.32 Million
Q3 2023

Nov 13, 2023

BUY
$57.89 - $64.73 $85,966 - $96,124
1,485 Added 7.61%
20,988 $1.22 Million
Q2 2023

Aug 14, 2023

BUY
$63.71 - $70.74 $268,155 - $297,744
4,209 Added 27.52%
19,503 $1.25 Million
Q1 2023

May 11, 2023

SELL
$65.71 - $74.53 $1.24 Million - $1.41 Million
-18,902 Reduced 55.28%
15,294 $1.06 Million
Q4 2022

Feb 07, 2023

SELL
$68.48 - $81.09 $2.97 Million - $3.52 Million
-43,408 Reduced 55.94%
34,196 $2.46 Million
Q3 2022

Nov 10, 2022

BUY
$0.13 - $76.84 $316 - $187,182
2,436 Added 3.24%
77,604 $5.53 Million
Q2 2022

Aug 08, 2022

SELL
$72.62 - $79.98 $16,847 - $18,555
-232 Reduced 0.31%
75,168 $5.8 Million
Q1 2022

May 06, 2022

SELL
$61.48 - $73.72 $289,386 - $347,000
-4,707 Reduced 5.88%
75,400 $4.71 Million
Q4 2021

Feb 09, 2022

BUY
$53.63 - $62.52 $4.3 Million - $5.01 Million
80,107 New
80,107 $5 Million

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $113B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Connectus Wealth, LLC Portfolio

Follow Connectus Wealth, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Connectus Wealth, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Connectus Wealth, LLC with notifications on news.